Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Professor Fran Platt has been appointed as the new Head of Department for Pharmacology at the University of Oxford. Fran took up her new post with effect from 1 June 2020 and will serve for an initial period of five years.

Professor Fran PlattFran has been with the University of Oxford since 1989, initially joining the Department of Biochemistry before moving to Pharmacology in 2006. Fran’s research group has a long-term interest in understanding and treating lysosomal storage diseases, a group of inherited metabolic diseases typically characterized by severe pathology in the brain, and her work spans basic cell biology, disease mechanism and therapy.

Originally studying Zoology at Imperial College before moving to the University of Bath to complete her PhD in Animal Physiology, Fran began her career in the US at Washington University and Monsanto Inc before moving back the UK to join the University of Oxford.

She is a Fellow of the Academy of Medical Sciences, the Society of Biology and Academia Europaea and a Trustee of the Gordon Research Conferences.

Fran has a particular interest in the development of early career scientists and is an active member of the Department’s Athena SWAN committee. She has also served for many years as a mentor for younger colleagues, both informally and formally via the Medical Sciences Division and the Royal Society.

Similar stories

International collaboration by Potter group uncovers vital element in regulation of Na⁺/K⁺- ATPase-α1

Department

An international collaboration of the Potter Group with Solomon Snyder’s Group in the USA and with Chinese and German colleagues has uncovered the myo-inositol polyphosphate pyrophosphate 5-InsP7 as a regulator of the Na⁺/K⁺- ATPase-α1

Professor Angela Russell receives 2021 Harrington UK Rare Disease Scholar Award

Department Russell Group

Angela Russell, Professor of Medicinal Chemistry in the Oxford Departments of Pharmacology and Chemistry, has been announced as one of the five recipients of the inaugural UK Rare Disease Scholar Award, presented by the Harrington Discovery Institute (HDI).

The Department mourns the loss of three greats in neuropharmacology

Department

This summer three of the world’s most distinguished neurochemists died; each was a member of the Department during their outstanding scientific careers.

Professor Fran Platt secures £1M funding over two years for vital Parkinson's Disease research, in collaboration with Pfizer

Department

There is an increasing body of genetic and biochemical evidence that points toward lysosomal dysfunction as a risk factor for developing age-related neurodegenerative disorders, including Parkinson’s disease (PD).

New Galione group paper explores the role for early Ca2+ signals in phagocytosis

Department

The Galione Lab has a paper published in The EMBO Journal showing that local Ca2+‐nanodomains formed by two‐pore channels (TPCs) on endo-lysosomes are shown to drive phagocytosis in macrophages. Moreover, different endo-lysosomal Ca2+ channels do different jobs at phagocytosis (extreme compartmentation).